Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients

MLA

Di Sabatino, A., et al. Infliximab Downregulates Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor in Crohn’s Disease Patients. Jan. 2004. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....3a6854860ea01a5d29f16d95e4d7d7db&authtype=sso&custid=ns315887.

APA

Di Sabatino, A., Ciccocioppo, R., Benazzato, L., Sturniolo, G., & Corazza, G. R. (2004). Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn’s disease patients.

Chicago

Di Sabatino, A., R. Ciccocioppo, L. Benazzato, Giacomo Sturniolo, and G. R. Corazza. 2004. “Infliximab Downregulates Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor in Crohn’s Disease Patients,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....3a6854860ea01a5d29f16d95e4d7d7db&authtype=sso&custid=ns315887.